2024 News Releases
-
Sept 17, 2024 - Beckman Coulter and Scopio Labs Add World’s First Digital Bone Marrow Imaging and Analysis to Long-Term Partnership
-
July 30, 2024 - Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s Disease
-
July 24, 2024 - Beckman Coulter’s DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.’s Annual Supplier Innovation Celebration
-
July 9, 2024 - Beckman Coulter Introduces New Integrated Chemistry and Immunoassay Analyzer
-
May 29, 2024 - Beckman Coulter Secures FDA Clearance for Heart Failure Assay on DxI 9000 Immunoassay Analyzer
-
May 7, 2024 - Beckman Coulter and MeMed Extend Partnership Advancing Host Immune Response Diagnostics
-
March 11, 2024 - Beckman Coulter and Fujirebio Expand Partnership to Develop Patient-friendly Blood-based Neurodegenerative Disease Diagnostics
-
April 16, 2024 - Beckman Coulter’s DxI 9000 Immunoassay Analyzer Extends Menu with New CE-Marked Hepatitis Assays at ESCMID Global
-
February 6, 2024 - Beckman Coulter Diagnostics Appoints Kevin O’Reilly as New President
-
January 30, 2024 - Beckman Coulter Unveils DxC 500 AU Chemistry Analyzer, Expanding Portfolio with Proven Six Sigma Performance
2020 News Releases
-
December 18, 2020 - Beckman Coulter launches one of the First High-Quality, High-Throughput COVID-19 Antigen Test Ideal for Mass Testing in the U.S.
-
November 23, 2020 - Beckman Coulter launches its semi-quantitative SARS-CoV-2 IgG II antibody test
-
November 10, 2020 - Beckman Coulter launches its SARS-CoV-2 IgM antibody test in countries accepting CE Mark and will begin shipping to diagnostics labs
-
October 15, 2020 - Beckman Coulter receives BARDA funding to validate Monocyte Distribution Width in the rapid detection of Multisystem Inflammatory Syndrome (MIS-C)
-
October 09, 2020 - Beckman Coulter SARS-CoV-2 IgM Antibody Test Receives FDA Emergency Use Authorization
-
October 06, 2020 - Beckman Coulter completes first in a series of antibody neutralization studies
-
October 01, 2020 - FDA Emergency Use Authorization awarded to the Beckman Coulter Access IL-6 test
-
August 24, 2020 - Beckman Coulter Launches SARS-CoV-2 IgM Antibody Test and will begin shipping to U.S. Diagnostics Labs
-
August 5, 2020 - Study shows patients with abnormal values of Beckman Coulter’s novel MDW biomarker are four- to six- times more likely to be diagnosed with (or develop) sepsis
-
July 22, 2020 - Beckman Coulter’s Automated Blood Banking Analyzer Receives 510(k) FDA Clearance
-
July 21, 2020 - Beckman Coulter Wins SelectScience Awards for Best New Clinical Instrumentation and Customer Service of the Year
-
July 17, 2020 - Beckman Coulter Receives Nine IMV ServiceTrak™ Clinical Laboratory Awards
-
July 06, 2020 - Beckman Coulter, Lenco Diagnostic Laboratories deliver more than 20,000 highly accurate COVID-19 antibody tests each week to New York City
-
June 29, 2020 - Beckman Coulter’s SARS-CoV-2 IgG Antibody Test Receives FDA Emergency Use Authorization
-
June 15, 2020 - Beckman Coulter’s SARS-CoV-2 IgG antibody test now available in markets accepting the CE Mark
-
May 18, 2020 - Beckman Coulter launches DxH 690T mid-volume hematology analyzer, featuring the Early Sepsis Indicator in U.S. market
-
May 15, 2020 - Beckman Coulter awarded expanded partnership with BARDA to assess sepsis diagnostic and prediction algorithm with COVID-19 patients
-
April 22, 2020 - Beckman Coulter announces May launch of its SARS-CoV-2 serology test and ramps production to deliver over 30 million tests per month
-
March 31, 2020 - Beckman Coulter announces development of tests to detect coronavirus antibodies
-
January 28 2020 - Beckman Coulter’s Access PCT Procalcitonin Assay receives U.S. FDA 510(k) clearance
-
January 7, 2020 - Beckman Coulter announces installation of DxH 900 and Early Sepsis Indicator at award-winning NHS pathology partnership
2019 News Releases
-
October 29 2019 - Beckman Coulter receives BARDA funding to develop algorithm to aid in the early detection of sepsis*
-
October 21, 2019 - Mid-size suv laboratories can now enjoy the same efficiency benefits as large facilities with Beckman Coulter's new hematology analyzer
-
October 9, 2019 - Beckman Coulter’s DxA 5000 total laboratory automation solution receives U.S. FDA 510(k) clearance
-
August 6, 2019 - Beckman Coulter MicroScan Wins IMV ServiceTrak™ Best System Performance for the Second Year in a Row
-
August 1, 2019 - Laboratories of all Sizes Can Now Harness the Power of Automation with Beckman Coulter
-
May 2, 2019 - Beckman Coulter Introduces Total Laboratory Automation Solution That Sets New Standard for Turnaround Time
-
April 18, 2019 - Beckman Coulter’s Early Sepsis Indicator Receives 510(k) Clearance from the U.S. Food and Drug Administration
-
March 26, 2019 - Beckman Coulter’s New Procalcitonin Assay Helps Physicians Accurately Identify Patients at Risk for Progression to Septic Shock
-
March 21, 2019 - Beckman Coulter’s Compact, Low-volume Hematology Analyzer Receives FDA 510(k) Clearance
-
March 7, 2019 - Beckman Coulter’s HbA1c Advanced Assay Provides Physicians with Greater Accuracy when Diagnosing Patients with Diabetes
2018 Press Releases
-
December 19, 2018 - Beckman Coulter’s New DxONE Workflow Manager Enables Low-volume Laboratories to Improve Turnaround Time and Maximize Staff Efficiency
-
December 3, 2018 - Beckman Coulter Diagnostics Joins with Sepsis Alliance to Help Improve Sepsis Patient Outcomes
-
November 27, 2018 - Beckman Coulter’s New DxONE Inventory Manager Helps Laboratory Professionals Save Time and Money
-
October 16, 2018 - Beckman Coulter Diagnostics Joins Forces with Johns Hopkins Medicine in Healthcare Innovation Initiative
-
September 10, 2018 - Beckman Coulter Announces Release of Latest Innovations to Middleware Software
-
September 4, 2018 - Beckman Coulter Sponsors 2nd World Sepsis Conference
-
August 1, 2018 - Beckman Coulter Announces Commercialization of DxM MicroScan WalkAway System
-
July 27, 2018 - Beckman Coulter and U.S. ARKRAY, Inc., Announce Partnership and Launch of the iQ Workcell to Deliver Scalable, Harmonized Solutions in the United States
-
July 23, 2018 - Beckman Coulter Diagnostics Brings Clinical Innovations to 70th AACC Annual Meeting and Clinical Laboratory Expo
-
July 19, 2018 - Beckman Coulter Announces Launch of DxONE PROService in Europe
-
June 27, 2018 - Beckman Coulter Diagnostics Receives U.S. FDA 510(k) Clearance for High-sensitivity Access hsTnI Assay
-
June 26, 2018 - Beckman Coulter Diagnostics Receives Health Canada Clearance for Access hsTnI, its New High Sensitivity Troponin Assay
-
June 25, 2018 - Beckman Coulter Files a 510(k) Submission with the FDA for Its Early Sepsis Indicator*
-
June 21, 2018 - UCI, Beckman Coulter Diagnostics announce strategic collaboration
-
June 20, 2018 - Health Canada Licenses Beckman Coulter’s Access Sensitive Estradiol Assay
-
June 19, 2018 - Pivotal Study Reveals Effectiveness of Blood Tests in Screening for Sleep Apnea in Adult Males
-
May 10, 2018 - Beckman Coulter Diagnostics Launches New Hematology Analyzer Software to Help Laboratories Deliver Quality Results with Greater Productivity
-
May 3, 2018 Beckman Coulter Achieves CE Mark for Its Early Sepsis Indicator*
-
May 1, 2018 - Beckman Coulter Launches the DxH 900 Hematology Analyzer
-
April 18, 2018 - Beckman Coulter Diagnostics Announces CE Mark of the DxH 520* Closed Tube, 5-part Differential Hematology Analyzer for Small-volume Labs
-
April 17, 2018 - Beckman Coulter Sponsors Top-ranked Sepsis Clinical Guide App to Empower Clinicians Caring for Patients in Acute Settings
-
April 10, 2018 - Beckman Coulter Diagnostics Announces Worldwide Commercialization of the Access Sensitive Estradiol
-
March 15, 2018 - Technopath Clinical Diagnostics and Beckman Coulter Diagnostics Enter Global Distribution Agreement
-
February 20, 2018 - Beckman Coulter Diagnostics in Partnership with NTE-SENER Announces European Launch of DxM 6100 Autoplak Advanced System
-
January 4, 2018 - Beckman Coulter Diagnostics Adds 6-Acetylmorphine (6-AM) and Buprenorphine (BUP) Assays to Comprehensive Chemistry Test Menu
2017 News Releases
-
December 21, 2017 - Beckman Coulter Diagnostics announced FDA clearance of its automated Access AMH immunoassay
-
November 27, 2017 - Beckman Coulter Enters Commercial Dispute with Quidel to Sell BNP Directly
-
November 21, 2017 - Recently published study reports a significant reduction in biopsy procedures performed when Prostate Health Index (phi) testing is used by physicians in routine clinical practice
-
November 7, 2017 - Beckman Coulter Diagnostics Receives CE Mark Clearance for its High-sensitivity Access hsTnI Assay
-
August 10, 2017 - Beckman Coulter Diagnostics Announces Enhancements to the Access 2 Immunoassay System
-
July 27, 2017 - Beckman Coulter Diagnostics Introduces DxONE™ Clinical Information Management Tools
-
July 20, 2017 - Partnering Today for a Stronger Tomorrow: Beckman Coulter Showcases Solutions for Navigating the Changing Healthcare Landscape
-
June 21, 2017 - Beckman Coulter Diagnostics Expands Chemistry Menu to include FDA-cleared Procalcitonin (PCT)
-
June 12, 2017 - The future of laboratory services revealed at EuroMedLab 2017: The Beckman Coulter Diagnostics Difference
-
April 20, 2017 - Beckman Coulter Diagnostics Receives CE Mark and Expands Chemistry Menu to include Procalcitonin (PCT)
2016 News Releases
-
December 16, 2016 - Henry Ford Health System Enhances Patient Care through Laboratory Automation Partnership
-
October 21, 2016 - Grady Health System Improves Patient Care with Enhanced Laboratory Services through Beckman Coulter Partnership
-
October 17, 2016 - FDA Clears Commercial Release of Access TSH (3rd IS) Assay for Beckman Coulter Immunoassay Systems
-
October 13, 2016 - Laboratory of the Year Award Winner PCL Alverno to Highlight Partnership with Beckman Coulter Diagnostics as Key Component of their Success at Upcoming Lab Quality Confab
-
August 30, 2016 - DiaSorin and Beckman Coulter Form Strategic Partnership to Bring the Liaison XL Hepatitis and HIV Products to the U.S. Market
-
August 3, 2016 - Beckman Coulter and Augusta University’s Medical Center Sign Fifteen Year Agreement Collaborating on Innovative Methods to Improve Patient Outcomes
-
August 2, 2016 - Advancing Patient Care through Laboratory Excellence: Beckman Coulter Showcases Integrated Product-Service Solutions at 2016 AACC Annual Scientific Meeting and Clinical Lab Expo
-
June 23, 2016 - Beckman Coulter introduces Sentinel Pancreatic Amylase reagent and calibrator on AU Clinical Chemistry Analyzers
-
June 8, 2016 - Beckman Coulter and Ortho Clinical Diagnostics Announce Strategic Relationship to Deliver Infectious Disease Testing Menu to Very High-Volume Labs
-
May 6, 2016 - Beckman Coulter Features Prostate Health Index (phi) at 2016 AUA Annual Meeting